About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cox17tm1Kako
targeted mutation 1, Koichiro Kako
MGI:2388937
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cox17tm1Kako/Cox17tm1Kako involves: 129X1/SvJ * C57BL/6J MGI:3510402


Genotype
MGI:3510402
hm1
Allelic
Composition
Cox17tm1Kako/Cox17tm1Kako
Genetic
Background
involves: 129X1/SvJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cox17tm1Kako mutation (0 available); any Cox17 mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes develop normally until E6.5 but die between E8.5 and E10

cellular
• at E6.5, mutant embryos display severe reductions in cytochrome c oxidase (CCO) activity; the immunoreactivity of other COX subunits remains unaffected
• reduced CCO activity in embryonic and extraembryonic tissues is also observed at later stages of development

embryo
• at E7.5, mutant embryos appear severely retarded and more fragile upon dissection of the decidua
• at E8.5, the mutant embryonic region is smaller than the extraembryonic region, and the embryonic cavity is severely reduced
• at E8.5, many embryonic cells appear small and atrophic relative to wild-type; the presence of condensed nuclei suggests apoptosis

homeostasis/metabolism
N
• at E6.5, homozygotes exhibit normal succinate dehydrogenase activity as well as normal lactate dehydrogenase activity, suggesting normal glycolysis





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory